Published in Mod Pathol on December 01, 2002
Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol (2004) 1.44
Estrous cycle modulates ovarian carcinoma growth. Clin Cancer Res (2009) 1.05
Diffusion weighted imaging of the normal breast: reproducibility of apparent diffusion coefficient measurements and variation with menstrual cycle and menopausal status. Eur Radiol (2012) 1.01
Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle. Breast Cancer Res (2005) 1.00
The effect of Fucus vesiculosus, an edible brown seaweed, upon menstrual cycle length and hormonal status in three pre-menopausal women: a case report. BMC Complement Altern Med (2004) 0.99
Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging. Radiology (2011) 0.92
Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle. Radiology (2013) 0.90
Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo. Breast Cancer Res (2012) 0.89
Form and Function: how Estrogen and Progesterone Regulate the Mammary Epithelial Hierarchy. J Mammary Gland Biol Neoplasia (2015) 0.88
RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1. Stem Cell Reports (2015) 0.88
Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update. Int Semin Surg Oncol (2006) 0.79
Optical properties of the breast during spontaneous and birth control pill-mediated menstrual cycles. Lasers Med Sci (2009) 0.78
Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle. Ann Oncol (2013) 0.78
Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer. Eur Radiol (2015) 0.77
Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer. Mediators Inflamm (2016) 0.77
High hopes for RANKL: will the mouse model live up to its promise? Breast Cancer Res (2011) 0.76
Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women. Front Oncol (2016) 0.76
The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle. Reprod Biol Endocrinol (2010) 0.76
Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. Cancer Epidemiol Biomarkers Prev (2014) 0.76
In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium. Sci Rep (2016) 0.75
Diffusion-weighted breast MRI: Clinical applications and emerging techniques. J Magn Reson Imaging (2016) 0.75
Response of bilateral breasts to the endogenous hormonal fluctuation in a menstrual cycle evaluated using 3D MRI. Magn Reson Imaging (2012) 0.75
Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk. Front Oncol (2016) 0.75
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol (2010) 14.41
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res (2006) 6.35
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol (2008) 4.42
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med (2010) 4.38
A meta-analysis of human acellular dermis and submuscular tissue expander breast reconstruction. Plast Reconstr Surg (2012) 3.30
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat (2009) 2.85
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med (2010) 2.72
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst (2013) 2.56
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol (2014) 2.38
Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res (2010) 2.33
Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg (2012) 2.20
What are safe margins of resection for invasive and in situ breast cancer? Oncology (Williston Park) (2011) 2.08
A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett (2007) 2.08
Molecular profiling assays in breast cancer: are we ready for prime time? Oncology (Williston Park) (2012) 2.04
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene (2005) 1.89
Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol (2002) 1.88
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol (2013) 1.83
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat (2007) 1.75
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol (2008) 1.69
Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol (2005) 1.65
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res (2006) 1.58
SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer (2010) 1.56
Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.56
Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol (2012) 1.46
The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Res Treat (2011) 1.46
Surgery for the intact primary and stage IV breast cancer…lacking "robust evidence". Ann Surg Oncol (2013) 1.46
ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer. Cancer Biol Ther (2010) 1.44
Breast cancer stem cells and intrinsic subtypes: controversies rage on. Curr Stem Cell Res Ther (2009) 1.44
Superficial temporal artery pseudoaneurysm: diagnosis and preoperative planning with CT angiography. AJNR Am J Neuroradiol (2003) 1.40
Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer (2008) 1.34
FOXA1 as a therapeutic target for breast cancer. Expert Opin Ther Targets (2007) 1.34
The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Mol Cancer Ther (2005) 1.33
Extrathoracic metastases of thymic origin: a review of 35 cases. Mod Pathol (2011) 1.29
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat (2007) 1.29
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol (2014) 1.28
Atypical ductal hyperplasia: interobserver and intraobserver variability. Mod Pathol (2011) 1.28
FOXA1 in breast cancer. Expert Rev Mol Med (2009) 1.23
Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer. Clin Cancer Res (2006) 1.23
AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer. Mol Cell Biol (2008) 1.21
FOXA1 is an independent prognostic marker for ER-positive breast cancer. Breast Cancer Res Treat (2011) 1.17
Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover. Carcinogenesis (2007) 1.16
A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience. Cancer Invest (2007) 1.16
Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Clin Cancer Res (2006) 1.16
WHO types A and AB thymomas: not always benign. Mod Pathol (2010) 1.15
NuMA influences higher order chromatin organization in human mammary epithelium. Mol Biol Cell (2006) 1.14
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci U S A (2006) 1.13
Primary tumor resection in stage IV breast cancer: consistent benefit, or consistent bias? Ann Surg Oncol (2007) 1.13
Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. Breast Cancer Res (2003) 1.10
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue. Breast Cancer Res Treat (2006) 1.08
A comparison of ductoscopy-guided and conventional surgical excision in women with spontaneous nipple discharge. Ann Surg (2005) 1.08
Role of AKT isotypes in breast cancer. J Pathol (2013) 1.07
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models. Breast Cancer Res Treat (2012) 1.07
Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg (2012) 1.07
Pregnancy after breast cancer: if you wish, ma'am. Breast Cancer Res Treat (2011) 1.07
Array-based multiplex analysis of DNA methylation in breast cancer tissues. J Mol Diagn (2007) 1.07
Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Cancer (2008) 1.06
Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge. Clin Cancer Res (2009) 1.05
Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res (2011) 1.05
Towards large-scale histopathological image analysis: hashing-based image retrieval. IEEE Trans Med Imaging (2014) 1.05
Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes. Breast Cancer Res Treat (2006) 1.04
Computerized classification of intraductal breast lesions using histopathological images. IEEE Trans Biomed Eng (2011) 1.02
Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol (2006) 1.02
Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.01
ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer. Cancer Res (2013) 1.00
Prognostic indicators after surgery for thymoma. Ann Thorac Surg (2010) 1.00
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res (2005) 1.00
Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy. J Pathol (2006) 1.00
PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. J Cell Sci (2011) 1.00
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study. Breast Cancer Res Treat (2012) 0.99
Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations. Cancer Epidemiol Biomarkers Prev (2010) 0.97
Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. Cancer Nanotechnol (2012) 0.96
Association between recency of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol (2011) 0.96
Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores. Mod Pathol (2009) 0.96
The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis (2005) 0.95
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Breast Cancer Res Treat (2007) 0.95
Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model. Oncol Rep (2010) 0.95
Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet. Cancer Res (2010) 0.94
Effect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration. Biomacromolecules (2012) 0.94
Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Hum Pathol (2002) 0.93
Contralateral prophylactic mastectomy: what do we know and what do our patients know? J Clin Oncol (2011) 0.93
Role of E-cadherins in development of lymphatic tumor emboli. Cancer (2003) 0.93
Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast. Mod Pathol (2010) 0.93
Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank. Breast Cancer Res (2014) 0.92
Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer. Am J Pathol (2003) 0.92
Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant (2013) 0.92
Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue. J Steroid Biochem Mol Biol (2003) 0.91
A physiologic imaging pilot study of breast cancer treated with AZD2171. Clin Cancer Res (2006) 0.91
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. Clin Cancer Res (2009) 0.90
Identification of FDA-approved drugs targeting breast cancer stem cells along with biomarkers of sensitivity. Sci Rep (2013) 0.90
A prospective study of variability in mammographic density during the menstrual cycle. Breast Cancer Res Treat (2009) 0.90
Stage-specific regulation of adhesion molecule expression segregates epithelial stem/progenitor cells in fetal and adult human livers. Hepatol Int (2007) 0.90
Personalized medicine: the road ahead. Clin Breast Cancer (2011) 0.90
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients. J Neurooncol (2015) 0.90
Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options. Arch Pathol Lab Med (2015) 0.89
Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma. J Am Coll Surg (2005) 0.88
Establishment and characterization of a novel cell line derived from human thymoma AB tumor. Lab Invest (2012) 0.88
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer. Breast Cancer Res Treat (2010) 0.87